Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
The Tohoku Journal of Experimental Medicine
|
January 26, 2006
Lactation and risk of endometrial cancer in Japan: a case-control study
Chikako Okamura, Yoshitaka Tsubono, Kiyoshi Ito, et al.
Gynecologic Oncology
|
July 21, 2007
Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer
Toshio Fujimoto, Hiroshi Nanjyo, Akira Nakamura, et al.
Oncology Reports
|
May 24, 2008
A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study
Yoshihito Yokoyama, Tadao Takano, Kenji Nakahara, et al.
The Tohoku Journal of Experimental Medicine
|
December 28, 2012
Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen
Hideki Tokunaga, Satoru Nagase, Kosuke Yoshinaga, et al.
Oncology
|
August 11, 2007
Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma
Jun-ichi Akahira, Hideki Tokunaga, Masafumi Toyoshima, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 19, 2011
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)
Tadahiro Shoji, Eriko Takatori, Hideo Omi, et al.
Molecular and Clinical Oncology
|
March 21, 2014
Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer
Yoshihito Yokoyama, Masayuki Futagami, Jun Watanabe, et al.
International Journal of Clinical Oncology
|
July 10, 2019
Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition
Saori Mishima, Hiroya Taniguchi, Kiwamu Akagi, et al.
The Tohoku Journal of Experimental Medicine
|
November 9, 2013
Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma
Fumihiko Suzuki, Satoru Nagase, Kichiya Suzuki, et al.
The Tohoku Journal of Experimental Medicine
|
December 2, 2004
Retrospective analysis of concurrent chemoradiation with the combination of bleomycin, ifosfamide and cisplatin (BIP) for uterine cervical cancer
Michiko Aoki, Jun-Ichi Akahira, Hitoshi Niikura, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
The Tohoku Journal of Experimental Medicine
|
January 26, 2006
Lactation and risk of endometrial cancer in Japan: a case-control study
Chikako Okamura, Yoshitaka Tsubono, Kiyoshi Ito, et al.
Gynecologic Oncology
|
July 21, 2007
Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer
Toshio Fujimoto, Hiroshi Nanjyo, Akira Nakamura, et al.
Oncology Reports
|
May 24, 2008
A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study
Yoshihito Yokoyama, Tadao Takano, Kenji Nakahara, et al.
The Tohoku Journal of Experimental Medicine
|
December 28, 2012
Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen
Hideki Tokunaga, Satoru Nagase, Kosuke Yoshinaga, et al.
Oncology
|
August 11, 2007
Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma
Jun-ichi Akahira, Hideki Tokunaga, Masafumi Toyoshima, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 19, 2011
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)
Tadahiro Shoji, Eriko Takatori, Hideo Omi, et al.
Molecular and Clinical Oncology
|
March 21, 2014
Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer
Yoshihito Yokoyama, Masayuki Futagami, Jun Watanabe, et al.
International Journal of Clinical Oncology
|
July 10, 2019
Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition
Saori Mishima, Hiroya Taniguchi, Kiwamu Akagi, et al.
The Tohoku Journal of Experimental Medicine
|
November 9, 2013
Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma
Fumihiko Suzuki, Satoru Nagase, Kichiya Suzuki, et al.
The Tohoku Journal of Experimental Medicine
|
December 2, 2004
Retrospective analysis of concurrent chemoradiation with the combination of bleomycin, ifosfamide and cisplatin (BIP) for uterine cervical cancer
Michiko Aoki, Jun-Ichi Akahira, Hitoshi Niikura, et al.
Page
of 7